Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis
Clinical trial NCT03232073 · COMPLETED
Trial details
- NCT number
- NCT03232073
- Sponsor
- Actelion
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-05
- Primary completion
- 2024-01-16
- Enrollment
- 877
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.